All companies are provided with links , which
connect you directly to the company webpage for further research.

dizziness lymphedema

Subjects will be permitted to remain on certain standard CD
medications, including steroids and immunomodulators, while participating in
the study. The 3rd
Edition of World Guide to Pharmaceutical Industry has not only been updated
but it has also been strengthened with over 400 new young biopharmaceutical
companies world wide .

macular sarcoidosis

Now, at almost 30, the
five-time All-Pro player is widely regarded by football legends and experts as
one of the best offensive guards in the NFL. "My parents instilled in me the importance of
telling people," he explained. DUBLIN, Ireland, Research and Markets
(http://www.

sarcoid polyradiculoneuropat

Investigational, Human Anti-IL-12, Anti-IL-23 Monoclonal Antibody Focus of
Phase II Clinical Research Trial

CHESTERBROOK, Pa.
Epilepsy is the third most common neurological disorder in the United
States after Alzheimer's disease and stroke."

The Epilepsy Foundation, a national non-profit with affiliated
organizations throughout the United States, has led the fight against epilepsy
since 1968. To reflect changes we have
included a separate list of companies who have either filed for bankruptcy,
undergone M+A etc. Companies
can be further researched on from inside the application by linking search
queries directly to search engines like Google and PubMed.com
Fax: +353 1 4100 980

capillary lymphedema

com/cgi-bin/prnh/20040820/RESEARCH )
This exciting world intelligence CD-ROM on pharmaceutical industry has
become better, stronger and more intelligent in its 3rd Edition.

capillary cloverleaf

It is estimated that 500,000 Americans
and more than 400,000 people in Europe and Canada suffer from this
gastrointestinal disorder.I. The episodes can
be traced to genetic abnormalities , head trauma, infectious diseases that
spread to the brain, and other conditions. "We're tremendous fans of his, not only because of his
on-the-field heroics, but mostly because of his courage to speak candidly
about his own experience with epilepsy.researchandmarkets.

mycosis fibro

"We look forward to further analysis and evaluation of this
therapy as a potential treatment for patients with moderate to severe Crohn's
disease.
Epilepsy is not a single entity but a family of more than 40 syndromes that
affect 50 million people worldwide.

parkinsons sarcoid

Epilepsy is marked by recurring seizures. You don't have to feel
inferior to your friends if that's how you're feeling.
(Logo: http://www.researchandmarkets .

sarcoid demyelinating

, The Pittsburgh Steelers are going to
the Super Bowl and - to many people with epilepsy and their families - all
eyes will be on Pittsburgh All-Pro Guard Alan Faneca. Why? It's because he
has become an inspiration to almost 3 million Americans living with epilepsy. You can be yourself and
be open about it and move on and do what you're able to do.

Companies are described by all their targeted
therapeutic areas (see list below), short profile, contact information
(address , phone, fax), web address and email.

arteriovenous tbi

, Centocor, Inc. Riff,
MD, Medical Director, Advanced Clinical Research Institute, Anaheim,
California. The disease causes inflammation of the
gastrointestinal tract, typically resulting in symptoms such as diarrhea,
fever, abdominal pain and weight loss.

dizziness cloverleaf

Centocor 's products, developed primarily through monoclonal antibody
technology, help physicians deliver innovative treatments to improve human
health and restore patients' quality of life.

Epilepsy Foundation Salutes Steelers' Alan Faneca On Super Bowl Sunday

Faneca was diagnosed with epilepsy at age 15.

newscom. you
will find World Guide to Pharmaceutical Industry useful to locate M+A
candidates, customers, collaboration partners, competitors etc.

autoimmune sarcoid

arteriovenous cloverleaf

LANDOVER, Md.com/reports/c15309

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.

demyelinating cloverleaf

com/reports /c15309 ) has announced the addition
of World Guide to Pharmaceutical Industry 2005, 3rd ED to their offering.e.

Support groups related to specific health diseases or disorders.

sarcoid osteotomy

Patients will be monitored through 28 weeks with an additional
visit at week 54 for a final blood test. Centocor is a wholly owned
subsidiary of Johnson + Johnson, the worldwide manufacturer of healthcare
products. For additional information, please visit
http://www.org .

herfordshire vestibular

This brings the total number of corporate profiles
covered in this product to more than 2,700 from 54 different nations (see list
of nations presented below). Whether you are a CEO, business
developer, in/out licensing officer, venture capitalist, consultant etc.

cerebal rsd

announced today
the extension of patient enrollment for a Phase II trial to evaluate the
safety and efficacy of CNTO 1275 for reducing the signs and symptoms of active
Crohn's disease (CD), a serious gastrointestinal disorder."
Faneca also discussed in the interview why he is so open about his
epilepsy, and where he garners his strength to speak freely about this
unfairly stigmatized condition.

Therapeutic Areas Covered:

-- Addiction
-- Autoimmune /Inflammation
-- Biomaterial/Skin/Wound/ Blood products
-- Cancer
-- Cardiovascular
-- Dermatology
-- Gastroenterology
-- Genetic diseases
-- Growth hormone therapy
-- Hormone replacement therapy
-- Infectious diseases
-- Metabolic diseases
-- Neurological disorders
-- Odontology
-- Ophthalmic
-- Pain
-- Reproductive
-- Respiratory diseases
-- Urogenital Diseases

This report offers the following:

-- Find competitors, collaborations partners, M+A candidates etc.

malformation autoimmune

I was going to do everything normally. Hence, the 3rd
Edition of World Guide to Pharmaceutical Industry brings important information
closer to you from one source.

arteriovenous cloverleaf

Centocor Extends Patient Enrollment to Evaluate CNTO 1275 in Treatment of Active Crohn's Disease

"This study will evaluate the effect of a targeted, human anti-IL-12
monoclonal antibody on Crohn's disease and its symptoms," said Dennis S."
Patients who are eligible to participate in the 28-week study will be
randomized at week 0 to one of four treatment groups to receive active drug or
placebo.
"It's very difficult for many people - especially celebrities - to admit
to living with this unfairly stigmatized condition , let alone a five-time All-
Pro football player," Coelho continued. "Thanks to Faneca, people living with
epilepsy are finally seeing why epilepsy isn't a barrier to success.epilepsyfoundation.

tbi cerebal

D.), such as arthritis and inflammatory skin
diseases. It is equal in prevalence to
cerebral palsy , multiple sclerosis and Parkinson's disease combined.

rsd sarcoid

CNTO 1275 is a
human monoclonal antibody that targets interleukin 12 (IL-12) and interleukin
23 (IL-23), proteins that occur naturally in the immune system and are
believed to play a role in the inflammation associated with CD. investors, trade organizations , and associated
industry to that of pharmaceutical industry.

polyradiculoneuropat avm

For more information about clinical trial sites and specific study
protocol, please call 1-800-624-7994.M. "If you have a seizure and your family's not
around, people need to know what's going on with you."
"We're big fans of Alan Faneca," explained Tony Coelho, chair of the
Epilepsy Foundation.
World Guide to Pharmaceutical Industry was created for professionals
within the industry and for those with particular interest of the
pharmaceutical industry, i.

lymphedema avm

About Crohn's Disease
CD is a chronic inflammatory bowel disorder that commonly affects the
lower part of the small intestine and the large intestine and typically begins
in late childhood or early adulthood.

Research and Markets: Introducing The World Guide to Pharmaceutical Industry 2005

vestibular macular

About Centocor
Centocor is a leading biopharmaceutical company that creates, acquires and
markets cost-effective therapies that yield long-term benefits for patients
and the healthcare community. The company is dedicated to the research and
development of treatments for a wide range of diseases including cancer,
infectious diseases, cardiovascular and metabolic diseases and Immune-Mediated
Inflammatory Disorders (I. In the majority of cases, the
cause is unknown.
Interviewed recently in EpilepsyUSA, Faneca discussed growing up with
epilepsy and how he was never going to let it keep him from playing the game
he loved. "I honestly didn't let [epilepsy affect me]," Faneca said. By being open, you
don't have to feel like you're hiding something. The Foundation's goals are to ensure that people with seizures
are able to participate in all life experiences; and to prevent, control and
cure epilepsy through research, education, advocacy and services, so not
another moment is lost to seizures.
The World Guide to Pharmaceutical Industry CD-ROM product is based on CD-
ROM technology which includes smart database structure, find and sort options,
internet and email interactivity.

mycosis malformation

Seizures are caused by brief,
spontaneous disturbances in the brain's electrical activity. "I
wasn't going to let it.
-- Jump start competitive intelligence operations
-- Excellent starting point for world wide benchmarking
-- Compare portfolio and therapy focus with your peers
-- Speed up pro-active in-/outlicensing strategy work
-- Track companies over time using search engines
-- Show investors/board /management that you are right on top of industry
development

For more information visit
http://www.

malformation sarcoma

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)